Hasegawa, Tsukasa
Ariyasu, Ryo http://orcid.org/0000-0003-4393-9176
Tanaka, Hisashi
Saito, Ryota
Kawashima, Yosuke
Horiike, Atsushi
Sakatani, Toshio
Tozuka, Takehiro
Shiihara, Jun
Saiki, Masafumi
Tambo, Yuichi
Sonoda, Tomoaki
Miyazaki, Akito
Uematsu, Shinya
Tsuchiya-Kawano, Yuko
Yanagitani, Noriko
Nishino, Makoto
Article History
Received: 8 March 2023
Accepted: 19 May 2023
First Online: 27 May 2023
Declarations
:
: Tsukasa Hasegawa reports honoraria from AstraZeneca, Chugai Pharmaceutical, and Eli Lilly and Company. Ryo Ariyasu reports honoraria from AstraZeneca, Chugai Pharmaceutical, and Bristol-Myers Squibb. Hisashi Tanaka reports honoraria from AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Chugai Pharmaceutical Ono Pharmaceutical, and Pfizer. Yosuke Kawashima reports honoraria from AstraZeneca, Chugai Pharmaceutical, Eli Lilly and Company, and Taiho Pharmaceutical. Atsushi Horiike reports receiving grants from BeiGene, Chugai Pharmaceutical, Daiichi Sankyo, Merck Sharp & Dohme, and Nippon Kayaku and honoraria from AstraZeneca, Bristol-Myers Squibb, Chugai Pharmaceutical, Eli Lilly and Company, EP-SOGO, Kyowa Hakko Kirin, Merck Sharp & Dohme, Novartis, and Taiho Pharmaceutical. Takehiro Tozuka reports honoraria from AstraZeneca and Chugai Pharmaceutical. Yuichi Tambo reports honoraria from AstraZeneca, Chugai Pharmaceutical, Merck Sharp & Dohme, Takeda Pharmaceutical, and Taiho Pharmaceutical. Tomoaki Sonoda reports honoraria from AstraZeneca, Chugai Pharmaceutical, Kyowa Hakko Kirin, Ono Pharmaceutical, and Taiho Pharmaceutical. Shinya Uematsu reports honoraria from AstraZeneca, Chugai Pharmaceutical, Eli Lilly and Company, Kyowa Hakko Kirin, Nippon Kayaku, Novartis, Ono Pharmaceutical, Pfizer, and Takeda Pharmaceutical. Yuko Tsuchiya-Kawano reports honoraria from Bristol-Myers Squibb, Chugai Pharmaceutical, Kyowa Hakko Kirin, Ono Pharmaceutical, and Takeda Pharmaceutical. Noriko Yanagitani reports honoraria from AstraZeneca, Bayer Yakuhin, Bristol-Myers Squibb, Chugai Pharmaceutical, Eli Lilly and Company, Ono Pharmaceutical, Pfizer, and Takeda Pharmaceutical and receiving payment for expert testimony from Chugai Pharmaceutical. Makoto Nishino reports honoraria from AbbVie, AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Eli Lilly and Company, Janssen, Merck Sharp & Dohme, Nippon Kayaku, Novartis, Merck Serono, Ono Pharmaceutical, Pfizer, Takeda Pharmaceutical, and Taiho Pharmaceutical. All other authors have stated that they have no conflicts of interest.
: The studies included in the analysis were conducted in accordance with the Declaration of Helsinki and the good clinical practice guidelines and were approved by the institutional review board of The Jikei University Daisan Hospital.